Publication
Digital assets and applicable law: in defence of the lex situs
The lex situs is the shorthand Latin tag for the law of the place where an asset is situated.
Global | Publication | March 2016
The fourth edition of the Life Sciences Law Review provides an overview of legal issues of interest to pharmaceutical, biotechnology and medical device companies in 30 jurisdictions. As before, each chapter contains information on legal requirements relating to the key stages in the life cycle of a regulated product, from discovery, through the clinical development process, registration, manufacturing and promotion, plus other issues of special interest, such as pricing and reimbursement, special liability regimes, competition and commercial transactions in the context of the medical products business. Each of the chapters has been prepared by a recognised expert in the relevant jurisdiction, and the resulting work product will assist industry lawyers, regulatory affairs staff and others who need to have an understanding of the issues in each major market.
Publication
The lex situs is the shorthand Latin tag for the law of the place where an asset is situated.
Publication
Since HM Treasury published the new Cryptoassets Regulations and the Financial Conduct Authority (FCA) published its latest series of consultation papers (CP25/40, 41 and 42) in December 2025, we have a little more clarity on the approach that is likely to be taken to various providers of cryptoasset services, including operators of cryptoasset trading platforms (CATPs).
Publication
As far as the Mergers and Acquisitions (M&A) market is concerned, 2025 turned out to be a tale of two halves. The year began very positively with a downward trajectory in inflation and interest rates expected throughout 2025, and a pro-business deregulatory stance anticipated in the US under the second Trump presidency.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2026